Gomatou G - Search Results

1

Molecular interactions of antibodies with PD-1/PD-L1 proteins.

Vasilakaki S, Vathiotis I, Panagiotou E, Dimakakos E, Gomatou G, Kotteas E. Vasilakaki S, et al. Among authors: gomatou g. Immunotherapy. 2024 Jan;16(1):21-28. doi: 10.2217/imt-2023-0165. Epub 2023 Dec 6. Immunotherapy. 2024. PMID: 38054258

2

Do we need prophylactic anticoagulation in ambulatory patients with lung cancer? A review.

Dimakakos E, Kotteas E, Gomatou G, Katsarou T, Vlahakos V, Vathiotis I, Talagani S, Dimitroulis I, Syrigos K. Dimakakos E, et al. Among authors: gomatou g. Vasc Med. 2020 Jun;25(3):255-262. doi: 10.1177/1358863X19899160. Epub 2020 Mar 7. Vasc Med. 2020. PMID: 32146869 Review.

3

Risk Factors for Venous Thromboembolism in Patients With Small Cell Lung Cancer.

Dimakakos E, Livanios K, Vathiotis I, Gomatou G, Gkiozos I, Kotteas E, Kainis E, Syrigos K. Dimakakos E, et al. Among authors: gomatou g. Anticancer Res. 2021 Mar;41(3):1523-1528. doi: 10.21873/anticanres.14911. Anticancer Res. 2021. PMID: 33788745

4

Tumor Dormancy: Implications for Invasion and Metastasis.

Gomatou G, Syrigos N, Vathiotis IA, Kotteas EA. Gomatou G, et al. Int J Mol Sci. 2021 May 4;22(9):4862. doi: 10.3390/ijms22094862. Int J Mol Sci. 2021. PMID: 34064392 Free PMC article. Review.

5

Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis.

Vathiotis IA, Gomatou G, Stravopodis DJ, Syrigos N. Vathiotis IA, et al. Among authors: gomatou g. Int J Mol Sci. 2021 May 20;22(10):5383. doi: 10.3390/ijms22105383. Int J Mol Sci. 2021. PMID: 34065396 Free PMC article. Review.

6

Emerging therapies in thymic epithelial tumors (Review).

Dapergola A, Gomatou G, Trontzas I, Panagiotou E, Dimakakos E, Syrigos N, Kotteas E. Dapergola A, et al. Among authors: gomatou g. Oncol Lett. 2023 Jan 16;25(2):84. doi: 10.3892/ol.2023.13670. eCollection 2023 Feb. Oncol Lett. 2023. PMID: 36760515 Free PMC article. Review.

7

Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options.

Gomatou G, Syrigos N, Kotteas E. Gomatou G, et al. Cancers (Basel). 2023 Jan 30;15(3):841. doi: 10.3390/cancers15030841. Cancers (Basel). 2023. PMID: 36765799 Free PMC article. Review.

8

Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials.

Panagiotou E, Gomatou G, Trontzas IP, Syrigos N, Kotteas E. Panagiotou E, et al. Among authors: gomatou g. Clin Transl Oncol. 2022 Feb;24(2):161-192. doi: 10.1007/s12094-021-02688-5. Epub 2021 Aug 7. Clin Transl Oncol. 2022. PMID: 34363593 Review.

9

BRAF/MEK inhibition in NSCLC: mechanisms of resistance and how to overcome it.

Tsamis I, Gomatou G, Chachali SP, Trontzas IP, Patriarcheas V, Panagiotou E, Kotteas E. Tsamis I, et al. Among authors: gomatou g. Clin Transl Oncol. 2023 Jan;25(1):10-20. doi: 10.1007/s12094-022-02849-0. Epub 2022 Jun 21. Clin Transl Oncol. 2023. PMID: 35729451 Review.

10

Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives.

Vathiotis IA, Trontzas I, Gavrielatou N, Gomatou G, Syrigos NK, Kotteas EA. Vathiotis IA, et al. Among authors: gomatou g. Clin Breast Cancer. 2022 Oct;22(7):642-649. doi: 10.1016/j.clbc.2022.06.004. Epub 2022 Jul 7. Clin Breast Cancer. 2022. PMID: 35906130 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters